14-day Premium Trial Subscription Try For FreeTry Free
Investor optimism is high on CONMED (CNMD) stock, courtesy of its solid prospects.
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice Presi
CONMED Corporation (CNMD) CEO Curt Hartman on Q4 2020 Results - Earnings Call Transcript

Conmed (CNMD) Q4 Earnings Surpass Estimates

06:20pm, Wednesday, 27'th Jan 2021
Conmed (CNMD) delivered earnings and revenue surprises of 7.69% and -3.91%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Conmed: Q4 Earnings Insights

05:35pm, Wednesday, 27'th Jan 2021
Shares of Conmed (NYSE:CNMD) were flat in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share were down 6.67% over the past year to $0.84, which beat the e
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced financial results for the fourth quarter ended December 31, 2020. Fourth Quarter 2020 Highlights Sales of $252.8 million d
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the fourth quarter and full year 2020 after the market close on Wednesday, Janua
MCK vs. CNMD: Which Stock Is the Better Value Option?
UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, President, Chief Executive Officer and Chair of the Board, and Todd W. Garner, Executive Vice Presid
UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on January 5, 2021 to all s
CONMED Corporation's (CNMD) CEO Curt Hartman on Q3 2020 Results - Earnings Call Transcript

Recap: Conmed Q3 Earnings

04:40pm, Wednesday, 28'th Oct 2020
Shares of Conmed (NYSE:CNMD) decreased 2.4% in after-market trading after the company reported Q3 results. Quarterly Results
The Global Diagnostic Electrodes Market will grow by $ 307.09 mn during 2020-2024
Equities analysts predict that CONMED Co. (NYSE:CNMD) will post $0.29 earnings per share (EPS) for the current fiscal quarter, Zacks reports. Five analysts have issued estimates for CONMED’s earning
Brokerages predict that CONMED Co. (NYSE:CNMD) will report earnings of $0.29 per share for the current quarter, according to Zacks Investment Research. Five analysts have made estimates for CONMED’s
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE